EUVIMEDEUVIMED entdecken
Crossref

Urolithin A exerts anti-tumor effects on gastric cancer via activating autophagy-Hippo axis and modulating the gut microbiota

Yixiao Qiao, Qiaoyun Xia, Xukun Cao, Jingyuan Xu, Zhengdong Qiao, Longyun Wu, Zhirong Chen, Longbao Yang, Xiaolan Lu

Naunyn-Schmiedeberg's Archives of Pharmacology · 2024-09 · 397 (9) · 6633-6645

DOI: 10.1007/s00210-024-03043-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 15.03.2024. Verfasst von Yixiao Qiao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, the Affiliated Suzhou Hospital of Nanjing Medical University, 16 Baita West Road, Suzhou, 215001, China. Hauptthemen laut MEDLINE: Autophagy, Stomach Neoplasms, Gastrointestinal Microbiome, Coumarins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: the Affiliated Suzhou Hospital of Nanjing Medical University, National Natural Science Foundation of China, Pudong New Area Clinical Characteristic Discipline Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastric cancer (GC) treatment regimens are still unsatisfactory. Recently, Urolithin A (UroA) has gained tremendous momentum due to its anti-tumor properties. However, the therapeutic effect and underlying mechanisms of UroA in GC are unclear. We explored the effects and related mechanisms of UroA on GC both in vivo and in vitro. A Cell Counting Kit-8 was used to determine the influence of UroA on the proliferation of GC cell lines. The Autophagy inhibitor 3-methyladenine (3MA) was employed to clarify the role of autophagy in the anti-tumor effect of UroA. Simultaneously, we detected the core-component proteins involved in autophagy and its downstream pathways. Subsequently, the in vivo anti-tumor effect of UroA was determined using a xenograft mouse model. Western blotting was used to detect the core protein components of the anti-tumor pathways, and 16S rDNA sequencing was used to detect the effect of UroA on the gut microbiota. We found that UroA suppressed tumor progression. The use of 3MA undermined the majority of the inhibitory effect of UroA on tumor cell proliferation, further confirming the importance of autophagy in the anti-tumor effect of UroA. Invigorating of autophagy activated the downstream Hippo pathway, thereby inhibiting the Warburg effect and promoting cell apoptosis. In addition, UroA modulated the composition of the gut microbiota, as indicated by the increase of probiotics and the decrease of pathogenic bacteria. Our research revealed new anti-tumor mechanisms of UroA, which may be a promising candidate for GC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutophagyStomach NeoplasmsGastrointestinal MicrobiomeCoumarinsCell ProliferationAnimalsHumansCell Line, TumorMiceMice, NudeMice, Inbred BALB CAntineoplastic AgentsXenograft Model Antitumor AssaysSignal TransductionProtein Serine-Threonine KinasesMale

Stichwörter der Autor:innen

AutophagyGastric cancerGut microbiotaHippo pathwayUrolithin AWarburg effect

Substanzen

3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-oneCoumarinsAntineoplastic AgentsProtein Serine-Threonine Kinases

Autor:innen und Institutionen

  • Department of Gastroenterology, the Affiliated Suzhou Hospital of Nanjing Medical University, 16 Baita West Road, Suzhou, 215001, China.
  • Department of Gastroenterology, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, 2800 Gongwei Road, Pudong, Shanghai, 201399, China.
  • Center for Medical Research and Innovation, Shanghai Pudong Hospital of Fudan University, Shanghai, 201399, China.
  • Department of General Intensive Care Unit, Henan Provincial Chest Hospital, Zhengzhou, 450003, China.
  • Department of Gastroenterology, the Affiliated Suzhou Hospital of Nanjing Medical University, 16 Baita West Road, Suzhou, 215001, China. 498520087@qq.com.
  • Department of Gastroenterology, the Affiliated Suzhou Hospital of Nanjing Medical University, 16 Baita West Road, Suzhou, 215001, China. czr88188@163.com.

Förderung

  • the Affiliated Suzhou Hospital of Nanjing Medical University
  • National Natural Science Foundation of China
  • Pudong New Area Clinical Characteristic Discipline Project
  • Key Discipline of Shanghai Pudong Hospital

Zitieren

APA

Qiao, Y., Xia, Q., Cao, X., Xu, J., Qiao, Z., Wu, L., Chen, Z., Yang, L., & Lu, X. (2024). Urolithin A exerts anti-tumor effects on gastric cancer via activating autophagy-Hippo axis and modulating the gut microbiota. Naunyn-Schmiedeberg's Archives of Pharmacology, 397(9), 6633-6645. https://doi.org/10.1007/s00210-024-03043-5

Vancouver

Qiao Y, Xia Q, Cao X, Xu J, Qiao Z, Wu L, et al. Urolithin A exerts anti-tumor effects on gastric cancer via activating autophagy-Hippo axis and modulating the gut microbiota. Naunyn-Schmiedeberg's Archives of Pharmacology. 2024;397(9):6633-6645. doi:10.1007/s00210-024-03043-5

BibTeX
@article{Qiao2024,
  author = {Qiao, Yixiao and Xia, Qiaoyun and Cao, Xukun and Xu, Jingyuan and Qiao, Zhengdong and Wu, Longyun and Chen, Zhirong and Yang, Longbao and Lu, Xiaolan},
  title = {Urolithin A exerts anti-tumor effects on gastric cancer via activating autophagy-Hippo axis and modulating the gut microbiota},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2024},
  volume = {397},
  number = {9},
  pages = {6633--6645},
  doi = {10.1007/s00210-024-03043-5}
}
Kostenlos starten →